• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

150例肌萎缩侧索硬化症患者经内镜胃造口术喂养后的营养状况与生存情况

Nutrition and Survival of 150 Endoscopic Gastrostomy-Fed Patients with Amyotrophic Lateral Sclerosis.

作者信息

Sousa-Catita Diogo, Mascarenhas Paulo, Oliveira Cátia, Grunho Miguel, Santos Carla A, Cabrita João, Correia Paula, Fonseca Jorge

机构信息

Aging Lab, Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, Caparica, 2829-511 Almada, Portugal.

Residências Montepio, Serviços de Saúde, SA.Rua Julieta Ferrão N° 10-5°, 1600-131 Lisboa, Portugal.

出版信息

Nutrients. 2025 Apr 8;17(8):1292. doi: 10.3390/nu17081292.

DOI:10.3390/nu17081292
PMID:40284157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12030596/
Abstract

: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting motor neurons in the brain and spinal cord, leading to muscle weakness, atrophy, and paralysis. Treatment focuses on symptom management, using medication, physiotherapy, and nutritional support. In this context, endoscopic gastrostomy (PEG) can provide adequate feeding, hopefully improving nutrition and preventing complications. : We studied ALS patients undergoing PEG over three months post-procedure, using anthropometry ((BMI)-body mass index; (MUAC)-mid-upper arm circumference; (TSF)-tricipital skinfold; (MAMC)-mid-arm muscle circumference) and laboratory data (Albumin; Transferrin; total cholesterol and hemoglobin), evaluating survival, complications, and nutritional/clinical status. Statistical analysis included Kaplan-Meier survival estimation and Cox regression to assess nutritional markers associated with survival. : 150 ALS patients underwent gastrostomy, mostly older adults (mean age: 66.1 years; median: 67). Mean survival was 527 [95% CI: 432-622] days, median 318 [95% CI: 236-400]. ALS bulbar subtype, MUAC and MAMC positively impacted PEG-feeding survival time ( < 0.05, Wald test). During the first three months of PEG feeding, each unit increase (cm) in MUAC and MAMC lowered death risk by 10% and 11%, respectively, highlighting the importance of nutrition care for survival. The bulbar subtype showed higher PEG feeding survival, with a 55.3% lower death hazard than the spinal subtype. There were no major PEG complications. ALS patients present a high risk of malnutrition. Patients that improved MAMC and MUAC in the first three PEG-fed months presented longer survival. Early PEG nutrition, even when some oral feeding is still possible, may reinforce the preventative role of enteral feeding in maintaining nutrition and potentially improving survival.

摘要

肌萎缩侧索硬化症(ALS)是一种进行性神经退行性疾病,会影响大脑和脊髓中的运动神经元,导致肌肉无力、萎缩和瘫痪。治疗重点在于症状管理,采用药物治疗、物理治疗和营养支持。在此背景下,内镜下胃造口术(PEG)可提供充足的喂养,有望改善营养状况并预防并发症。

我们研究了在接受PEG术后三个月内的ALS患者,使用人体测量指标((BMI)——体重指数;(MUAC)——上臂中部周长;(TSF)——三头肌皮褶厚度;(MAMC)——上臂中部肌肉周长)和实验室数据(白蛋白;转铁蛋白;总胆固醇和血红蛋白),评估生存率、并发症以及营养/临床状况。统计分析包括Kaplan-Meier生存估计和Cox回归,以评估与生存相关的营养标志物。

150例ALS患者接受了胃造口术,大多数为老年人(平均年龄:66.1岁;中位数:67岁)。平均生存期为527[95%置信区间:432 - 622]天,中位数为318[95%置信区间:236 - 400]天。ALS延髓亚型、MUAC和MAMC对PEG喂养生存时间有积极影响(P<0.05,Wald检验)。在PEG喂养的前三个月,MUAC和MAMC每增加一个单位(厘米),死亡风险分别降低10%和11%,凸显了营养护理对生存的重要性。延髓亚型的PEG喂养生存率更高,死亡风险比脊髓亚型低55.3%。没有发生重大的PEG并发症。

ALS患者存在营养不良的高风险。在PEG喂养的前三个月中MAMC和MUAC得到改善的患者生存期更长。早期PEG营养,即使在仍有部分经口喂养可能的情况下,也可能加强肠内喂养在维持营养和潜在改善生存方面的预防作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/43ce0eeb3271/nutrients-17-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/8ee996f8d453/nutrients-17-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/1c7611c051e0/nutrients-17-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/b724d9bdf79b/nutrients-17-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/43ce0eeb3271/nutrients-17-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/8ee996f8d453/nutrients-17-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/1c7611c051e0/nutrients-17-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/b724d9bdf79b/nutrients-17-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58e/12030596/43ce0eeb3271/nutrients-17-01292-g004.jpg

相似文献

1
Nutrition and Survival of 150 Endoscopic Gastrostomy-Fed Patients with Amyotrophic Lateral Sclerosis.150例肌萎缩侧索硬化症患者经内镜胃造口术喂养后的营养状况与生存情况
Nutrients. 2025 Apr 8;17(8):1292. doi: 10.3390/nu17081292.
2
Enteral feeding through endoscopic gastrostomy in amyotrophic lateral sclerosis patients.肌萎缩侧索硬化症患者通过内镜下胃造口术进行肠内营养喂养。
Nutr Hosp. 2016 Sep 20;33(5):561. doi: 10.20960/nh.561.
3
Feeding tube transparietal thickness - A promising anthropometric parameter for nutritional assessment of endoscopic gastrostomy fed patients.饲管经壁厚度——一种用于评估接受内镜下胃造口术喂养患者营养状况的有前景的人体测量参数。
Clin Nutr ESPEN. 2019 Feb;29:224-230. doi: 10.1016/j.clnesp.2018.10.001. Epub 2018 Oct 24.
4
Malnutrition, Cancer Stage and Gastrostomy Timing as Markers of Poor Outcomes in Gastrostomy-Fed Head and Neck Cancer Patients.营养不良、癌症分期和胃造口术时机是胃造口喂养的头颈部癌症患者预后不良的标志物。
Nutrients. 2023 Jan 28;15(3):662. doi: 10.3390/nu15030662.
5
What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?经皮内镜下胃造口术对肌萎缩侧索硬化症患者生存率的相关性是什么?
Amyotroph Lateral Scler. 2012 Oct;13(6):550-4. doi: 10.3109/17482968.2012.684215. Epub 2012 Jun 18.
6
Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者的经皮内镜下胃造口术与肠内营养
J Neurol. 1995 Oct;242(10):695-8. doi: 10.1007/BF00866922.
7
Malnutrition and Clinical Outcome of 234 Head and Neck Cancer Patients who Underwent Percutaneous Endoscopic Gastrostomy.234例行经皮内镜下胃造口术的头颈癌患者的营养不良状况及临床结局
Nutr Cancer. 2016 May-Jun;68(4):589-97. doi: 10.1080/01635581.2016.1158297. Epub 2016 May 4.
8
Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS).经皮内镜下胃造口术(PEG)对肌萎缩侧索硬化症(ALS)患者疾病演变的影响。
Nutrients. 2021 Aug 12;13(8):2765. doi: 10.3390/nu13082765.
9
Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis: Mortality and complications.肌萎缩侧索硬化患者的经皮内镜下胃造口术:死亡率和并发症
Neurologia (Engl Ed). 2019 Nov-Dec;34(9):582-588. doi: 10.1016/j.nrl.2018.01.003. Epub 2018 Mar 26.
10
Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease.营养支持团队增加运动神经元病患者经皮内镜胃造瘘术的接受率。
World J Gastroenterol. 2012 Nov 28;18(44):6461-7; discussion p.6466. doi: 10.3748/wjg.v18.i44.6461.

本文引用的文献

1
Percutaneous gastrostomy, mechanical ventilation and survival in amyotrophic lateral sclerosis: an observational study in an incident cohort.经皮胃造口术、机械通气与肌萎缩侧索硬化患者生存:一项队列研究
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):563-569. doi: 10.1080/21678421.2024.2351185. Epub 2024 May 15.
2
Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis.经皮内镜下胃造口术在肌萎缩侧索硬化症患者中的时机和影响:全面分析。
Sci Rep. 2024 Mar 26;14(1):7103. doi: 10.1038/s41598-024-56752-5.
3
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD).
欧洲神经病学学会(EAN)与欧洲神经肌肉疾病参考网络(ERN EURO-NMD)合作制定的肌萎缩侧索硬化症管理指南。
Eur J Neurol. 2024 Jun;31(6):e16264. doi: 10.1111/ene.16264. Epub 2024 Mar 12.
4
MOTOR NEURON LOSS IN AGING AND AMYOTROPHIC LATERAL SCLEROSIS: DIFFERENT FUSE LENGTHS, SAME EXPLOSION.衰老和肌萎缩侧索硬化症中的运动神经元丧失:保险丝长度不同,爆炸相同。
Physiol Mini Rev. 2020 Jan-Feb;13(1):1-11.
5
Amyotrophic lateral sclerosis.肌萎缩性侧索硬化症。
Lancet. 2022 Oct 15;400(10360):1363-1380. doi: 10.1016/S0140-6736(22)01272-7. Epub 2022 Sep 15.
6
Musculoskeletal Aging and Sarcopenia in the Elderly.肌肉骨骼衰老与老年人的肌肉减少症。
Int J Mol Sci. 2022 Mar 4;23(5):2808. doi: 10.3390/ijms23052808.
7
[Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options].[肌萎缩侧索硬化症(ALS)——诊断、病程及治疗选择]
Dtsch Med Wochenschr. 2021 Dec;146(24-25):1613-1618. doi: 10.1055/a-1562-7882. Epub 2021 Dec 8.
8
Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis.肌萎缩侧索硬化症患者生存的预测因素:一项大型荟萃分析。
EBioMedicine. 2021 Dec;74:103732. doi: 10.1016/j.ebiom.2021.103732. Epub 2021 Dec 1.
9
Assessment of the Nutritional Status of the Hemodialysis Patients by Anthropometric Measurements.通过人体测量评估血液透析患者的营养状况。
Cureus. 2021 Oct 8;13(10):e18605. doi: 10.7759/cureus.18605. eCollection 2021 Oct.
10
Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS).经皮内镜下胃造口术(PEG)对肌萎缩侧索硬化症(ALS)患者疾病演变的影响。
Nutrients. 2021 Aug 12;13(8):2765. doi: 10.3390/nu13082765.